# **Automated Dispensing Machine Usage Reducing Medication Errors

According to the National Center for Biotechnology Information (NCBI), nearly 7,000–9,000 human lives are lost every year in the U.S. due to medication errors. Similarly, the Canadian Patient Safety Institute (CPSI) states that nearly 10% of the patient safety incidents in the country are caused due to faulty medication. Such errors can be primarily attributed to the lack of proper healthcare medication administration and weak communication between patients and medical professionals. The increasing incidence of medication errors can be significantly reduced by the deployment of automated dispensing machines in abundance.


Additionally, the rising geriatric population will aid the automated dispensing machines market to advance at a CAGR of 9.1% during the forecast period (2021–2030). The market revenue stood at $1,673.0 million in 2020 and it is projected to reach $3,941.9 million by 2030. The World Ageing Population 2020 report estimates that the population of people aged 65 years or above will grow from 727 million in 2020 to over 1.5 billion by 2050. As old people are highly prone to chronic diseases and require advanced care, their booming population is creating a huge demand for these machines.

In recent years, automated dispensing machine manufacturers have been focusing on product launches to attract more customers. For instance, in April 2021, Omnicell Inc. launched Medimat, a new robotic dispensing system, for the Middle Eastern pharmaceutical sector. Likewise, in January 2020, TouchPoint Medical Inc. introduced the next-generation medDispense series that delivers multiple dispensing options and security across one software platform. This new product line supports single-line-item control, bulk item storage, and single-dose dispensing, while using one software platform medLogicTM.

The type segment of the automated dispensing machines market is bifurcated into centralized and decentralized. Under this segment, the decentralized category will demonstrate the faster growth throughout the forecast period. This can be majorly ascribed to the surging cases of hospitalization and the burgeoning number of hospitals. The increasing prevalence of chronic diseases such as cardiovascular diseases (CVDs), neurological disorders, and gastroenterological illnesses will drive the demand for decentralized automated dispensing systems, as patients suffering from such diseases need to be hospitalized regularly for proper treatment.

According to P&S Intelligence, North America adopted the highest number of automated dispensing machines in the past, and it is expected to retain its industry leadership in the coming years as well. This can be primarily credited to the booming aging population and improving healthcare infrastructure in the region. According to the United States Census Bureau, by 2050, the population of people aged 65 years and above will account for approximately 21.4% of the total population of North America. Besides, the presence of prominent automated dispensing machine manufacturers is also encouraging the usage of such machines in the region.

**Access Report Summary [Automated Dispensing Machines Market Growth Analysis](https://www.psmarketresearch.com/market-analysis/automated-dispensing-machines-market)
**